JanOleKemnadeMD

PubMed

• Phase I / II trial of metformin as a chemo-radiosensitizer in a head and neck cancer patient population.
  Jan O Kemnade, Marcus Florez, Anita Sabichi, Jun Zhang, Pavan Jhaveri, George Chen, Albert Chen, Courtney Miller-Chism, Bulsara Shaun, Susan G Hilsenbeck, David J Hern...> ;Oral Oncology. 2023 Oct 1
• Deployment of cisplatin in Veterans with oropharyngeal cancer: toxicity and impact on oncologic outcomes.
  Ola Soliman, David C Wilde, Jan O Kemnade, Anita L Sabichi, George Chen, Albert Chen, Samantha N Little, Andrew T Huang, David J Hernandez, Vlad C Sandulache> ;Laryngoscope Investigative Otolaryngology. 2023 Aug 1
• 14 citations
  Oropharyngeal cancer outcomes correlate with p16 status, multinucleation and immune infiltration.
  David C Wilde, Patricia D Castro, Kaustav Bera, Syeling Lai, Anant Madabhushi, German Corredor, Can Koyuncu, James S Lewis Jr, Cheng Lu, Mitchell J Frederick, Allan M ...> ;Modern Pathology. 2022 Aug 1
• 8 citations
  Persistent ethnicity-associated disparity in anti-tumor effectiveness of immune checkpoint inhibitors despite equal access.
  Marcus A Florez, Jan O Kemnade, Nan Chen, Wendy Du, Anita L Sabichi, Daniel Y Wang, Quillan Huang, Courtney N Miller-Chism, Aparna Jotwani, Albert C Chen, David Hernan...> ;Cancer Research Communications. 2022 Jul 26
• 2 citations
  Non-small cell lung cancer in the era of immunotherapy.
  Quillan Huang, Jan Kemnade, Loraine Cornwell, Farrah Kheradmand, Anita L Sabichi, Devika Das> ;Seminars in Oncology. 2022 Jul 8
• 5 citations
  Consistent multimodality approach to oral cavity and high-risk oropharyngeal cancer in veterans.
  David J. Hernandez, Bahar Alam, Jan O. Kemnade, Andrew T. Huang, Albert C. Chen, Vlad C. Sandulache> ;American Journal of Otolaryngology. 2021 Jul 27
• 25 citations
  Metformin generates profound alterations in systemic and tumor immunity with associated antitumor effects
  Ratna Veeramachaneni, Wangjie Yu, Jared M. Newton, Jan O. Kemnade, Heath D. Skinner, Andrew G. Sikora, Vlad C. Sandulache> ;Journal for Immunotherapy of Cancer. 2021 Jul 1
• 4 citations
  Human epidermal growth factor receptor 2 expression in head and neck squamous cell carcinoma: Variation within and across primary tumor sites, and implications for ant...
  Emilie A K Warren, Joshua Anil, Patricia Castro, Jan O. Kemnade, Masataka Suzuki, Meenakshi Hegde, John Hicks, Wendong Yu, Vlad C. Sandulache, Andrew G. Sikora> ;Head & Neck. 2021 Mar 4
• 15 citations
  CD8 infiltration is associated with disease control and tobacco exposure in intermediate-risk oropharyngeal cancer
  Jan Ole Kemnade, Hesham Elhalawani, Patricia Castro, Jin Yu, S. Lai, Michael Ittmann, Abdallah S.R. Mohamed, Stephen Y. Lai, Clifton D. Fuller, Andrew G. Sikora, Vlad ...> ;Scientific Reports. 2020 Jan 14
• 34 citations
  Clinicopathological features and clinical outcomes associated with TP53 and BRAFNon‐V600 mutations in cutaneous melanoma patients
  Dae Won Kim, Lauren E. Haydu, Aron Y. Joon, Roland L. Bassett, Alan E. Siroy, Michael T. Tetzlaff, Mark J. Routbort, Rodabe N. Amaria, Jennifer A. Wargo, Jennifer L. M...> ;Cancer. 2017 Apr 15
• 24 citations
  Tobacco mosaic virus efficiently targets DC uptake, activation and antigen-specific T cell responses in vivo.
  Jan Ole Kemnade, Mamatha Seethammagari, Mathew Collinson-Pautz, Hardeep Kaur, David M. Spencer, Alison A. McCormick> ;Vaccine. 2014 Jul 16
• 5 citations
  Off-the-shelf Adenoviral-mediated Immunotherapy via Bicistronic Expression of Tumor Antigen and iMyD88/CD40 Adjuvant
  Jan Ole Kemnade, Mamatha Seethammagari, Priya Narayanan, Jonathan M. Levitt, Alison A. McCormick, David M. Spencer> ;Molecular Therapy. 2012 Jul 1
• Join now to see all